DK576887A - Farmaceutiske midler - Google Patents

Farmaceutiske midler

Info

Publication number
DK576887A
DK576887A DK576887A DK576887A DK576887A DK 576887 A DK576887 A DK 576887A DK 576887 A DK576887 A DK 576887A DK 576887 A DK576887 A DK 576887A DK 576887 A DK576887 A DK 576887A
Authority
DK
Denmark
Prior art keywords
thromboxane
pharmaceutical agents
antagonises
dioxan
medicines
Prior art date
Application number
DK576887A
Other languages
English (en)
Other versions
DK576887D0 (da
Inventor
Andrew George Brewster
George Robert Brown
Michael James Smithers
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of DK576887D0 publication Critical patent/DK576887D0/da
Publication of DK576887A publication Critical patent/DK576887A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK576887A 1986-11-04 1987-11-03 Farmaceutiske midler DK576887A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868626297A GB8626297D0 (en) 1986-11-04 1986-11-04 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK576887D0 DK576887D0 (da) 1987-11-03
DK576887A true DK576887A (da) 1988-05-05

Family

ID=10606757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK576887A DK576887A (da) 1986-11-04 1987-11-03 Farmaceutiske midler

Country Status (13)

Country Link
US (1) US4908380A (da)
EP (1) EP0266980B1 (da)
JP (1) JPS63130532A (da)
AT (1) ATE81774T1 (da)
AU (1) AU608546B2 (da)
CA (1) CA1308660C (da)
DE (1) DE3782396T2 (da)
DK (1) DK576887A (da)
ES (1) ES2052581T3 (da)
GB (1) GB8626297D0 (da)
GR (1) GR3006099T3 (da)
IL (1) IL84261A (da)
ZA (1) ZA877886B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5248780A (en) * 1988-02-16 1993-09-28 Imperial Chemical Industries, Plc Pyridyl substituted alkenoic acid derivatives
GB8901201D0 (en) * 1988-02-16 1989-03-15 Ici Plc Pyridine derivatives
GB9021571D0 (en) * 1990-10-04 1990-11-21 Ici Plc Heterocyclic acids
US20110178112A1 (en) 2006-01-18 2011-07-21 Evolva Sa PPAR Modulators
EP2150111B1 (en) 2007-01-18 2016-10-19 Evolva SA Substituted 1,3-dioxanes useful as ppar modulators
MX2009007667A (es) * 2007-01-18 2011-12-08 Evolva Sa Profarmacos de 1,3-dioxanos sustituidos y sus usos.
AR072297A1 (es) 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2111050B (en) * 1981-11-19 1985-09-11 Ciba Geigy Ag N-substituted-2-pyridylindoles
GB8310407D0 (en) * 1982-05-12 1983-05-25 Ici Plc 1 3 - dioxan -5- ylalkenoic acids
GB8330120D0 (en) * 1983-11-11 1983-12-21 Ici Plc Chemical process
GB8511890D0 (en) * 1985-05-10 1985-06-19 Ici Plc Benzene derivatives
GB8619450D0 (en) * 1986-08-08 1986-09-17 Glaxo Group Ltd Chemical compositions

Also Published As

Publication number Publication date
CA1308660C (en) 1992-10-13
DE3782396T2 (de) 1993-07-08
EP0266980A2 (en) 1988-05-11
IL84261A (en) 1991-12-15
EP0266980B1 (en) 1992-10-28
ZA877886B (en) 1988-05-04
DK576887D0 (da) 1987-11-03
ATE81774T1 (de) 1992-11-15
US4908380A (en) 1990-03-13
GB8626297D0 (en) 1986-12-03
GR3006099T3 (da) 1993-06-21
ES2052581T3 (es) 1994-07-16
AU608546B2 (en) 1991-04-11
AU8069887A (en) 1988-05-05
DE3782396D1 (de) 1992-12-03
EP0266980A3 (en) 1989-11-08
JPS63130532A (ja) 1988-06-02

Similar Documents

Publication Publication Date Title
MX9203370A (es) Desulfatohirudina y composiciones farmaceuticas que la contienen.
SE8700498D0 (sv) Novel pharmaceologically active compounds
EP0564739A3 (da)
IT1254915B (it) Derivati di adenosina ad attivita' a2 agonista
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
FR2694004B1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
FI890311A0 (fi) Kemiska foereningar.
FI914409A0 (fi) Kalciumupptagande inhibitorer.
SE8404065D0 (sv) Novel biologically active compounds
SE8505488D0 (sv) Isosilybinfri silibinin
DK576887D0 (da) Farmaceutiske midler
FI891986A0 (fi) Farmaceutiska sammansaettningar foer behandling av psoriasis.
ES433860A1 (es) Procedimiento de preparacion de derivados del acido ciclo- pentano-carboxilico.
NO913683D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
ATE112168T1 (de) Menschlicher hitzeschock-faktor.
EP0266979A3 (en) Therapeutic agents
FI914410A0 (fi) Kalciumupptagande inhibitorer.
IT8123540A0 (it) Procedimento per la preparazione di composti citostatici e composizioni farmaceutiche contenenti gli stessi.
SE8704049D0 (sv) Novel pharmacological compounds
JO1711B1 (en) Therapeutic agents

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment